Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains.
- Join NJ ACTS for a Special Lecture on 12/19, 12-1:30
- NJIT Researcher Uses Nanoparticles to Develop Cancer Therapies.
- Researchers Suggest Stress Hormones Explain How Obesity Causes Diabetes.
- Rutgers Study Reveals Vaccination Patterns Among LGBTQ+ Adults in New Jersey and New York.
Categories
- Community (2,077)
- Covid (979)
- CTO Events (5)
- News (2,638)
- Pilots (20)